Max Link is Director at ALEXION PHARMACEUTICALS INC (ALXN). They have made 20 open-market trades across 5 companies since 2006, most recently 2014-08-12.
CIK 0001050944
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
14 open-market purchases totalling $880K since 2006, against 6 sales. Across 8 scored buys the stock is up 0.0% at ninety days, and 0.3 points behind the S&P over the same stretch.
8 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 0% | 0% | 0% |
| Avg Move | -28.5% | +0.0% | +0.0% |
| Alpha | -22.7% | -0.3% | -0.3% |
| Scored | 8 | 8 | 8 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ALXN | SELL | 2014-02-03 | 2014-02-05 | $155.16 | $6.2M | -15.6% | -1.2% | -1.2% |
| CLSN | BUY | 2012-12-10 | 2012-12-11 | $7.60 | $106K | -28.5% | +0.0% | +0.0% |
| ALXN | SELL | 2012-08-14 | 2012-08-15 | $103.89 | $10.4M | -15.6% | -1.2% | -1.2% |
| CYTR | BUY | 2012-02-22 | 2012-02-24 | $0.32 | $66K | N/A | N/A | N/A |
| CLSN | BUY | 2011-07-25 | 2011-07-27 | $4.27 | $200K | -28.5% | +0.0% | +0.0% |
| CLSN | BUY | 2011-05-26 | 2011-05-31 | $2.77 | $96K | -28.5% | +0.0% | +0.0% |
| ALXN | SELL | 2011-02-28 | 2011-03-01 | $95.00 | $4.5M | -15.6% | -1.2% | -1.2% |
| ALXN | SELL | 2011-02-22 | 2011-02-23 | $95.00 | $4.5M | -15.6% | -1.2% | -1.2% |
| ALXN | SELL · Routine | 2010-02-18 | 2010-02-23 | $49.34 | $2.0M | -15.6% | -1.2% | -1.2% |
| CLSN | BUY | 2009-12-22 | 2009-12-23 | $3.00 | $30K | -28.5% | +0.0% | +0.0% |
| CLSN | BUY | 2009-08-10 | 2009-08-11 | $3.71 | $56K | -28.5% | +0.0% | +0.0% |
| CLSN | BUY | 2009-05-13 | 2009-05-14 | $3.90 | $59K | -28.5% | +0.0% | +0.0% |
| ALXN | SELL | 2009-04-27 | 2009-04-29 | $33.94 | $1.4M | -15.6% | -1.2% | -1.2% |
| CLSN | BUY | 2008-11-19 | 2008-11-21 | $2.70 | $6K | -28.5% | +0.0% | +0.0% |
| CLSN | BUY | 2008-11-17 | 2008-11-18 | $2.76 | $20K | -28.5% | +0.0% | +0.0% |
| CLN | BUY | 2007-05-18 | 2007-05-21 | $4.84 | $48K | N/A | N/A | N/A |
| DSCO | BUY | 2007-03-09 | 2007-03-13 | $2.09 | $84K | N/A | N/A | N/A |
| CLN | BUY | 2007-02-27 | 2007-03-01 | $3.49 | $35K | N/A | N/A | N/A |
| CLN | BUY | 2007-02-26 | 2007-02-27 | $3.50 | $35K | N/A | N/A | N/A |
| ALXN | SELL | 2006-08-10 | 2006-09-06 | $31.60 | $524K | -15.6% | -1.2% | -1.2% |
| CLN | BUY | 2006-03-17 | 2006-03-17 | $4.03 | $40K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| Total |
| $11.6M |
Shares reported on the most recent Form 4, priced at the 2014-08-14 close. 5 holdings could not be priced and are excluded from the total.